CCL2 and idiopathic pulmonary fibrosis: These findings further support the critical role of chemotaxis in the pathogenesis of IPF and highlight IL-8 and MCP-1 as potential therapeutic targets for modulating the immune microenvironment in the lower respiratory tract.